Sundrug Co.,Ltd. (SDGCF)
USD 28.18
(0.0%)
USD 28.18
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 148.31 Billion JPY | 14551.05% |
| 2023 | 1.01 Billion JPY | 0.63% |
| 2022 | 1 Billion JPY | -8.29% |
| 2021 | 1.09 Billion JPY | 0.34% |
| 2020 | 1.09 Billion JPY | 8.09% |
| 2019 | 1.01 Billion JPY | 2.56% |
| 2018 | 986.15 Million JPY | 13.65% |
| 2017 | 867.73 Million JPY | 7.06% |
| 2016 | 810.48 Million JPY | -99.02% |
| 2015 | 82.3 Billion JPY | 5.82% |
| 2014 | 77.78 Billion JPY | 8.33% |
| 2013 | 71.8 Billion JPY | 6.19% |
| 2012 | 67.62 Billion JPY | 81.07% |
| 2011 | 37.34 Billion JPY | 27.53% |
| 2010 | 29.28 Billion JPY | 24.85% |
| 2009 | 23.45 Billion JPY | 9.16% |
| 2008 | 21.48 Billion JPY | -34.46% |
| 2007 | 32.78 Billion JPY | 19.62% |
| 2006 | 27.41 Billion JPY | 19.99% |
| 2005 | 22.84 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 262.22 Million JPY | 5.85% |
| 2024 Q1 | 244.69 Million JPY | -10.49% |
| 2024 Q2 | 247.74 Million JPY | 1.25% |
| 2024 Q4 | 38.97 Billion JPY | 14764.27% |
| 2024 FY | 148.31 Billion JPY | 14551.05% |
| 2023 FY | 1.01 Billion JPY | 0.63% |
| 2023 Q3 | 262.94 Million JPY | 16.31% |
| 2023 Q2 | 226.07 Million JPY | -0.82% |
| 2023 Q1 | 227.94 Million JPY | -11.26% |
| 2023 Q4 | 273.37 Million JPY | 3.97% |
| 2022 Q2 | 276.44 Million JPY | 3.45% |
| 2022 Q1 | 267.23 Million JPY | -4.45% |
| 2022 Q3 | 267.14 Million JPY | -3.36% |
| 2022 Q4 | 256.85 Million JPY | -3.85% |
| 2022 FY | 1 Billion JPY | -8.29% |
| 2021 Q2 | 30.72 Billion JPY | 8.34% |
| 2021 FY | 1.09 Billion JPY | 0.34% |
| 2021 Q1 | 28.35 Billion JPY | -4.31% |
| 2021 Q4 | 279.67 Million JPY | -99.1% |
| 2021 Q3 | 31.22 Billion JPY | 1.63% |
| 2020 Q2 | 30.2 Billion JPY | 4.88% |
| 2020 FY | 1.09 Billion JPY | 8.09% |
| 2020 Q1 | 28.8 Billion JPY | 2.27% |
| 2020 Q3 | 29.37 Billion JPY | -2.75% |
| 2020 Q4 | 29.63 Billion JPY | 0.88% |
| 2019 FY | 1.01 Billion JPY | 2.56% |
| 2019 Q1 | 27.18 Billion JPY | 1.17% |
| 2019 Q2 | 28.24 Billion JPY | 3.89% |
| 2019 Q3 | 28.34 Billion JPY | 0.35% |
| 2019 Q4 | 28.16 Billion JPY | -0.65% |
| 2018 Q4 | 26.87 Billion JPY | 0.63% |
| 2018 Q3 | 26.7 Billion JPY | 2.18% |
| 2018 Q2 | 26.13 Billion JPY | 3.89% |
| 2018 Q1 | 25.15 Billion JPY | 1.51% |
| 2018 FY | 986.15 Million JPY | 13.65% |
| 2017 FY | 867.73 Million JPY | 7.06% |
| 2017 Q3 | 24.68 Billion JPY | 2.95% |
| 2017 Q2 | 23.98 Billion JPY | 3.18% |
| 2017 Q1 | 23.24 Billion JPY | -1.8% |
| 2017 Q4 | 24.78 Billion JPY | 0.39% |
| 2016 FY | 810.48 Million JPY | -99.02% |
| 2016 Q2 | 22.69 Billion JPY | 4.83% |
| 2016 Q1 | 21.65 Billion JPY | 1.16% |
| 2016 Q3 | 23.07 Billion JPY | 1.68% |
| 2016 Q4 | 23.66 Billion JPY | 2.54% |
| 2015 FY | 82.3 Billion JPY | 5.82% |
| 2015 Q1 | 19.1 Billion JPY | -5.65% |
| 2015 Q4 | 21.4 Billion JPY | 0.12% |
| 2015 Q3 | 21.37 Billion JPY | 4.65% |
| 2015 Q2 | 20.42 Billion JPY | 6.91% |
| 2014 Q4 | 20.24 Billion JPY | 4.15% |
| 2014 FY | 77.78 Billion JPY | 8.33% |
| 2014 Q1 | 18.82 Billion JPY | 3.23% |
| 2014 Q2 | 19.27 Billion JPY | 2.37% |
| 2014 Q3 | 19.44 Billion JPY | 0.89% |
| 2013 Q4 | 18.23 Billion JPY | -0.25% |
| 2013 FY | 71.8 Billion JPY | 6.19% |
| 2013 Q1 | 17.38 Billion JPY | 263.31% |
| 2013 Q2 | 17.9 Billion JPY | 2.96% |
| 2013 Q3 | 18.28 Billion JPY | 2.11% |
| 2012 Q3 | 17.58 Billion JPY | 4.5% |
| 2012 Q2 | 16.83 Billion JPY | 4.67% |
| 2012 Q1 | 16.08 Billion JPY | 271.54% |
| 2012 FY | 67.62 Billion JPY | 81.07% |
| 2012 Q4 | -10.64 Billion JPY | -160.54% |
| 2011 Q1 | 15.06 Billion JPY | 430.68% |
| 2011 Q3 | 15.84 Billion JPY | 0.23% |
| 2011 Q2 | 15.8 Billion JPY | 4.93% |
| 2011 FY | 37.34 Billion JPY | 27.53% |
| 2011 Q4 | -9.37 Billion JPY | -159.16% |
| 2010 Q3 | 12.08 Billion JPY | 9.09% |
| 2010 Q1 | 10.67 Billion JPY | 0.0% |
| 2010 FY | 29.28 Billion JPY | 24.85% |
| 2010 Q4 | -4.55 Billion JPY | -137.7% |
| 2010 Q2 | 11.07 Billion JPY | 3.77% |
| 2009 FY | 23.45 Billion JPY | 9.16% |
| 2008 FY | 21.48 Billion JPY | -34.46% |
| 2007 FY | 32.78 Billion JPY | 19.62% |
| 2006 FY | 27.41 Billion JPY | 19.99% |
| 2005 FY | 22.84 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3437.19 USD | -4315123591.155% |
| Allstar Health Brands, Inc. | 215.74 Thousand USD | -68746626.49% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -268390.799% |
| Café Serendipity Holdings, Inc. | 1.43 Million USD | -10326435.727% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 47.57 Thousand USD | -311790944.776% |
| HealthWarehouse.com, Inc. | 13.79 Million USD | -1075018.387% |
| LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -189554.114% |
| MedGen, Inc. | 16.59 USD | -894026521901.206% |
| Omni Health, Inc. | 1.14 Million USD | -12930644.377% |
| Oxford Investments Holdings Inc. | 373.76 Thousand USD | -39682745.455% |
| Pineapple, Inc. | 452.94 Thousand USD | -32745159.942% |
| ScripsAmerica, Inc. | 31.4 Million USD | -472187.428% |